Health Canada & Canadian Society for Pharmaceutical Sciences - Use of Real World Data/Evidence to Inform Regulatory Decision Making
Real world data (RWD) and real world evidence (RWE) are playing increasing roles in health-care decisions. Real world data are routinely employed to support reimbursement and coverage decisions for drugs and devices. More recently, clinical trials incorporating pragmatic designs and observational st...
Saved in:
Main Author: | Real World Data Workshop Group CSPS/Health Canada (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proceedings of the 10th Canadian Society for Pharmaceutical Sciences, 64th Association of Faculties of Pharmacy of Canada and 18th Pharmaceutical & Biomedical Analysis Annual meetings
by: CSPS CSPS
Published: (2007) -
Comparison of two assessments of real‐world data and real‐world evidence for regulatory decision‐making
by: Lily Yuan, et al.
Published: (2024) -
Applying real-world data to support regulatory decision - making in the United States
by: M. A. Borzova, et al.
Published: (2021) -
12th Canadian Society for Pharmaceutical Sciences (CSPS) Annual Meeting, Toronto, Ontario, Canada. International Symposium on Pharmacy & Pharmaceutical Sciences: DRUG DEVELOPMENT TO REGULATORY APPROVAL
Published: (2009) -
Health Canada Usage of Real World Evidence (RWE) in Regulatory Decision Making compared with FDA/EMA usage based on publicly available information
by: Catherine Lau, et al.
Published: (2022)